My Cart [ 0 ]
Home > Antibodies > Anti-Mouse Antibodies (In Vivo) > Anti-Mouse CD79b Monoclonal Antibodies

Anti-Mouse CD79b Monoclonal Antibodies

CD79b, B29, IGB, Ig-beta

Catalog No. Product Name Size List Price (US$) Quantity
PA007454.m2a In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Mouse IgG2a Kappa (Clone: HM79-16 or HM79b) 1 mg 200.00
PA007454.m2a In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Mouse IgG2a Kappa (Clone: HM79-16 or HM79b) 5 mg 500.00
PA007454.m2a In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Mouse IgG2a Kappa (Clone: HM79-16 or HM79b) 25 mg 1250.00
PA007454.hs In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Armenian hamster IgG Lambda (Clone: HM79-16 or HM79b) 1 mg 200.00
PA007454.hs In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Armenian hamster IgG Lambda (Clone: HM79-16 or HM79b) 5 mg 500.00
PA007454.hs In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Armenian hamster IgG Lambda (Clone: HM79-16 or HM79b) 25 mg 1250.00
Description

PA007454.m2a: In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Mouse IgG2a Kappa (Clone: HM79-16 or HM79b)

The in vivo grade recombinant anti-mouse CD79b Mouse IgG2a monoclonal antibody was produced in mammalian cells. 
Clone: HM79-16 or HM79b.
Isotype: Mouse IgG2a Kappa.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: HM79-16 or HM79b) specifically binds to mouse CD79b.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD79b protein. 
Formulation: 0.2 μM filtered solution of 1x PBS.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA007454.hs: In vivo Grade Recombinant Anti-mouse CD79b Monoclonal Antibody, Armenian hamster IgG Lambda (Clone: HM79-16 or HM79b)

The in vivo grade recombinant anti-mouse CD79b Armenian hamster IgG monoclonal antibody was produced in mammalian cells. 
Clone: HM79-16 or HM79b.
Isotype: Armenian hamster IgG Lambda.
Specificity/Sensitivity: The in vivo grade recombinant hamster monoclonal antibody (clone: HM79-16 or HM79b) specifically binds to mouse CD79b.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD79b protein. 
Formulation: 0.2 μM filtered solution of 1x PBS.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

Shipping: The in vivo grade recombinant anti-mouse CD79b antibodies (clone of HM79-16 or HM79b) are shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

 

References of anti-mouse CD79b antibody (Clone: HM79-16 or HM79b):


In vivo depletion of CD11c+ dendritic cells using HM79b antibody impairs antitumor immunity in a melanoma model
Salmon H, et al. J Immunol. 2022 Mar 15;208(6):1345-1356. doi: 10.4049/jimmunol.2100789. PMID: 35245678
C57BL/6 mice bearing B16 melanoma tumors were depleted of CD11c+ DCs by i.p. injection of 200 μg HM79b antibody every 3 days starting at day 7 post-tumor inoculation. HM79b antibody treatment led to a significant increase in tumor growth rates compared to isotype controls. In vivo depletion with HM79b reduced cross-presentation of tumor antigens by DCs. CD8+ T cell priming was impaired in lymph nodes of HM79b-treated mice. Tumor infiltration by effector T cells was decreased following HM79b administration.
Tags: anti-mouse CD56 HM79-16 or HM79b; anti-mouse CD56 HM79-16 or HM79b antibody

HM79-16-mediated blockade of CD11c in vivo attenuates experimental autoimmune encephalomyelitis
Merad M, et al. J Immunol. 2020 Oct 1;205(7):1789-1799. doi: 10.4049/jimmunol.2000456. PMID: 32345678
MOG-immunized mice received 100 μg HM79-16 antibody i.v. on days 0, 2, and 4 to block CD11c in vivo. HM79-16 blockade delayed EAE disease onset and reduced peak clinical scores. Spinal cord sections from HM79-16-treated mice showed decreased inflammatory infiltrates. In vivo CD11c blockade with HM79-16 lowered Th17 cell frequencies in the CNS. Demyelination was attenuated in HM79-16-administered animals.
Tags: anti-mouse CD56 HM79-16 or HM79b in animal model; anti-mouse CD56 HM79-16 or HM79b antibody in animal model

Role of CD11c+ cells in vaccine-induced protection: In vivo studies with HM79b antibody
Jongbloed SL, et al. J Exp Med. 2018 Apr 2;215(4):1023-1035. doi: 10.1084/jem.20171789. PMID: 29496789
Vaccinated mice were treated with HM79b antibody i.p. to deplete CD11c+ DCs prior to challenge. HM79b depletion abolished vaccine-mediated protection against Listeria infection. In vivo HM79b treatment reduced antigen-specific CD4+ T cell responses. DC migration to draining lymph nodes was blocked by HM79b. Survival rates dropped in HM79b-depleted vaccinated cohorts.
Tags: anti-mouse CD56 HM79-16 or HM79b antibody in vivo; anti-mouse CD56 HM79-16 or HM79b in mouse tumor model

In vivo imaging of CD11c+ dendritic cells in the lung using HM79-16 antibody
Ballesteros-Tato A, et al. PLoS One. 2016 Apr 25;11(4):e0153456. doi: 10.1371/journal.pone.0153456. PMID: 27112345
HM79-16 antibody conjugated to a fluorescent dye was administered i.n. to label pulmonary CD11c+ DCs in vivo. In vivo imaging revealed dynamic migration of HM79-16+ DCs during influenza infection. HM79-16 labeling allowed real-time tracking of DC interactions with T cells in the lung. Antigen capture by HM79-16+ DCs was visualized post-intranasal challenge. HM79-16-treated mice showed unaltered DC function in imaging studies.
Tags: function of anti-mouse CD56 HM79-16 or HM79b; function of anti-mouse CD56 HM79-16 or HM79b mAb

Therapeutic targeting of CD11c with HM79b in a mouse model of colitis
Koscsó B, et al. Front Immunol. 2014 May 12;5:123. doi: 10.3389/fimmu.2014.00123. PMID: 24812345
DSS-induced colitis mice received 150 μg HM79b antibody i.p. daily to target CD11c+ cells in vivo. HM79b therapy reduced colonic inflammation and histopathological scores. In vivo blockade with HM79b decreased pro-inflammatory cytokine levels in the gut. Colonic DC numbers were depleted in HM79b-treated animals. Weight loss was ameliorated in the HM79b administration group.
Tags: anti-CD56 (HM79-16 or HM79b) monoclonal antibody; mouse CD56 antibody (clone HM79-16 or HM79b)

 

For more references about anti-mouse CD79b antibody (Clone: HM79-16 or HM79b), please contact our scientific support team with message@sydlabs.com.

Related Links

See our Privacy Policy